For years I had read about the dangers of the LABA class of drug. The primary concern is that the use of these drugs alone (without a steroid) lead to a higher incidence of death from an asthma attack. I am glad to see that the FDA has come out against the use of this class of drug in all patients, including teenagers.
If your teenager has asthma and is on Foradil, Serevent, or another long-acting beta agonist, contact your pediatric provider immediately. It is important for your child's asthma to be managed appropriately, so don't hesitate to discuss your concerns with the person who is there to protect your teen's health.